The ketogenic diet has been used as a therapy for refractory epilepsy in children since the 1920's. It was only recently, however, that a randomized, controlled study confirmed it to be effective in reducing seizures. Is there a role for the ketogenic diet as first-line therapy for epilepsy? Which patients stand to benefit the most from this diet, and what are some of its potential adverse effects? Dr. Douglas Nordli, associate professor of neurology and pediatrics at Northwestern University's Feinberg School of Medicine, and the Lorna S. and James P. Langdon Chair of Pediatric Epilepsy, offers details on this trial and explores mechanisms through which we may generate more timely results in our research for patients with epilepsy. Dr. Jennifer Shu hosts.
Ketogenic Diet for Refractory Epilepsy: Beyond Anecdotes

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The ketogenic diet has been used as a therapy for refractory epilepsy in children since the 1920's. It was only recently, however, that a randomized, controlled study confirmed it to be effective in reducing seizures. Is there a role for the ketogenic diet as first-line therapy for epilepsy? Which patients stand to benefit the most from this diet, and what are some of its potential adverse effects? Dr. Douglas Nordli, associate professor of neurology and pediatrics at Northwestern University's Feinberg School of Medicine, and the Lorna S. and James P. Langdon Chair of Pediatric Epilepsy, offers details on this trial and explores mechanisms through which we may generate more timely results in our research for patients with epilepsy. Dr. Jennifer Shu hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Updates From the 7th World Symposium Task Force
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?